| __timestamp | Exelixis, Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 189101000 | 68205000 |
| Thursday, January 1, 2015 | 96351000 | 54218000 |
| Friday, January 1, 2016 | 95967000 | 15934000 |
| Sunday, January 1, 2017 | 112171000 | 24390000 |
| Monday, January 1, 2018 | 182257000 | 25389000 |
| Tuesday, January 1, 2019 | 336964000 | 72324000 |
| Wednesday, January 1, 2020 | 547851000 | 184809000 |
| Friday, January 1, 2021 | 693716000 | 205164000 |
| Saturday, January 1, 2022 | 891813000 | 245441000 |
| Sunday, January 1, 2023 | 1044071000 | 271823000 |
| Monday, January 1, 2024 | 910408000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Exelixis, Inc. and Madrigal Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
Exelixis, Inc. has shown a remarkable upward trend, increasing its R&D budget by over 450% from 2014 to 2023. This surge reflects the company's aggressive pursuit of new therapies and treatments. In contrast, Madrigal Pharmaceuticals, Inc. has maintained a more conservative approach, with a 300% increase in the same period. Despite this, Madrigal's R&D spending in 2023 is still only about 26% of Exelixis's budget.
These figures highlight the diverse strategies within the biotech sector, where companies balance risk and innovation to drive future growth.
AstraZeneca PLC or Exelixis, Inc.: Who Invests More in Innovation?
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
United Therapeutics Corporation vs Exelixis, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Exelixis, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Exelixis, Inc.
Research and Development Investment: Exelixis, Inc. vs Alpine Immune Sciences, Inc.
Exelixis, Inc. or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Madrigal Pharmaceuticals, Inc. vs Opthea Limited
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Perrigo Company plc
Research and Development: Comparing Key Metrics for Madrigal Pharmaceuticals, Inc. and Vericel Corporation
Madrigal Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.